Sam Slutsky
Stock Analyst at LifeSci Capital
(2.94)
# 1,302
Out of 5,154 analysts
3
Total ratings
66.67%
Success rate
83.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sam Slutsky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PVLA Palvella Therapeutics | Initiates: Outperform | $90 | $134.39 | -33.03% | 1 | Aug 4, 2025 | |
| ABVX ABIVAX Société Anonyme | Maintains: Outperform | $45 → $101 | $109.33 | -7.62% | 1 | Jul 23, 2025 | |
| IFRX InflaRx | Upgrades: Outperform | n/a | $0.97 | - | 1 | Apr 5, 2023 |
Palvella Therapeutics
Aug 4, 2025
Initiates: Outperform
Price Target: $90
Current: $134.39
Upside: -33.03%
ABIVAX Société Anonyme
Jul 23, 2025
Maintains: Outperform
Price Target: $45 → $101
Current: $109.33
Upside: -7.62%
InflaRx
Apr 5, 2023
Upgrades: Outperform
Price Target: n/a
Current: $0.97
Upside: -